Vanguard Group’s Heron Therapeutics HRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $17.5M | Buy |
8,471,460
+245,875
| +3% | +$509K | ﹤0.01% | 2616 |
|
|
2025
Q1 | $18.1M | Buy |
8,225,585
+67,976
| +0.8% | +$150K | ﹤0.01% | 2554 |
|
|
2024
Q4 | $12.5M | Sell |
8,157,609
-562,567
| -6% | -$861K | ﹤0.01% | 2832 |
|
|
2024
Q3 | $17.4M | Buy |
8,720,176
+104,254
| +1% | +$207K | ﹤0.01% | 2657 |
|
|
2024
Q2 | $30.2M | Buy |
8,615,922
+501,206
| +6% | +$1.75M | ﹤0.01% | 2366 |
|
|
2024
Q1 | $22.5M | Sell |
8,114,716
-224,196
| -3% | -$621K | ﹤0.01% | 2544 |
|
|
2023
Q4 | $14.2M | Buy |
8,338,912
+169,632
| +2% | +$288K | ﹤0.01% | 2763 |
|
|
2023
Q3 | $8.41M | Buy |
8,169,280
+28,558
| +0.4% | +$29.4K | ﹤0.01% | 2974 |
|
|
2023
Q2 | $9.44M | Sell |
8,140,722
-289,896
| -3% | -$336K | ﹤0.01% | 2980 |
|
|
2023
Q1 | $12.7M | Buy |
8,430,618
+624,333
| +8% | +$943K | ﹤0.01% | 2807 |
|
|
2022
Q4 | $19.5M | Sell |
7,806,285
-946,556
| -11% | -$2.37M | ﹤0.01% | 2638 |
|
|
2022
Q3 | $36.9M | Buy |
8,752,841
+790,644
| +10% | +$3.34M | ﹤0.01% | 2325 |
|
|
2022
Q2 | $22.2M | Sell |
7,962,197
-1,972,491
| -20% | -$5.5M | ﹤0.01% | 2589 |
|
|
2022
Q1 | $56.8M | Buy |
9,934,688
+325,643
| +3% | +$1.86M | ﹤0.01% | 2242 |
|
|
2021
Q4 | $87.7M | Buy |
9,609,045
+108,753
| +1% | +$993K | ﹤0.01% | 2059 |
|
|
2021
Q3 | $102M | Buy |
9,500,292
+180,564
| +2% | +$1.93M | ﹤0.01% | 1971 |
|
|
2021
Q2 | $145M | Buy |
9,319,728
+828,512
| +10% | +$12.9M | ﹤0.01% | 1806 |
|
|
2021
Q1 | $138M | Buy |
8,491,216
+179,448
| +2% | +$2.91M | ﹤0.01% | 1783 |
|
|
2020
Q4 | $176M | Buy |
8,311,768
+310,669
| +4% | +$6.58M | 0.01% | 1534 |
|
|
2020
Q3 | $119M | Sell |
8,001,099
-28,439
| -0.4% | -$421K | ﹤0.01% | 1597 |
|
|
2020
Q2 | $118M | Buy |
8,029,538
+45,073
| +0.6% | +$663K | ﹤0.01% | 1587 |
|
|
2020
Q1 | $93.7M | Buy |
7,984,465
+127,899
| +2% | +$1.5M | ﹤0.01% | 1563 |
|
|
2019
Q4 | $185M | Buy |
7,856,566
+900,519
| +13% | +$21.2M | 0.01% | 1431 |
|
|
2019
Q3 | $129M | Buy |
6,956,047
+211,189
| +3% | +$3.91M | ﹤0.01% | 1583 |
|
|
2019
Q2 | $125M | Buy |
6,744,858
+330,351
| +5% | +$6.14M | ﹤0.01% | 1627 |
|
|
2019
Q1 | $157M | Buy |
6,414,507
+100,168
| +2% | +$2.45M | 0.01% | 1500 |
|
|
2018
Q4 | $164M | Buy |
6,314,339
+121,090
| +2% | +$3.14M | 0.01% | 1373 |
|
|
2018
Q3 | $196M | Buy |
6,193,249
+1,661,318
| +37% | +$52.6M | 0.01% | 1400 |
|
|
2018
Q2 | $176M | Buy |
4,531,931
+1,734,743
| +62% | +$67.4M | 0.01% | 1438 |
|
|
2018
Q1 | $77.2M | Buy |
2,797,188
+379,908
| +16% | +$10.5M | ﹤0.01% | 1854 |
|
|
2017
Q4 | $43.8M | Buy |
2,417,280
+347,787
| +17% | +$6.3M | ﹤0.01% | 2128 |
|
|
2017
Q3 | $33.4M | Sell |
2,069,493
-26,972
| -1% | -$436K | ﹤0.01% | 2252 |
|
|
2017
Q2 | $29M | Buy |
2,096,465
+221,362
| +12% | +$3.07M | ﹤0.01% | 2295 |
|
|
2017
Q1 | $28.1M | Buy |
1,875,103
+537,563
| +40% | +$8.06M | ﹤0.01% | 2284 |
|
|
2016
Q4 | $17.5M | Buy |
1,337,540
+26,560
| +2% | +$348K | ﹤0.01% | 2478 |
|
|
2016
Q3 | $22.6M | Buy |
1,310,980
+95,637
| +8% | +$1.65M | ﹤0.01% | 2314 |
|
|
2016
Q2 | $21.9M | Buy |
1,215,343
+58,039
| +5% | +$1.05M | ﹤0.01% | 2289 |
|
|
2016
Q1 | $22M | Buy |
1,157,304
+54,940
| +5% | +$1.04M | ﹤0.01% | 2257 |
|
|
2015
Q4 | $29.4M | Buy |
1,102,364
+24,726
| +2% | +$660K | ﹤0.01% | 2137 |
|
|
2015
Q3 | $26.3M | Buy |
1,077,638
+182,312
| +20% | +$4.45M | ﹤0.01% | 2167 |
|
|
2015
Q2 | $27.9M | Buy |
895,326
+226,015
| +34% | +$7.04M | ﹤0.01% | 2203 |
|
|
2015
Q1 | $9.74M | Buy |
669,311
+93,504
| +16% | +$1.36M | ﹤0.01% | 2659 |
|
|
2014
Q4 | $5.79M | Buy |
575,807
+11,274
| +2% | +$113K | ﹤0.01% | 2817 |
|
|
2014
Q3 | $4.7M | Buy |
564,533
+77,609
| +16% | +$646K | ﹤0.01% | 2866 |
|
|
2014
Q2 | $6M | Buy |
+486,924
| New | +$6M | ﹤0.01% | 2748 |
|